[1] Zhu Z, Zhang T, Shen Y, et al.The burden of fracture in China from 1990 to 2019[J]. Arch Osteoporos, 2023, 19(1): 1-3. [2] Cianferotti L, Bifolco G, Caffarelli C, et al.Nutrition, vitamin D, and calcium in elderly patients before and after a hip fracture and their impact on the musculoskeletal system: A narrative review[J]. Nutrients, 2024, 16(11): 1773. [3] Xu B, Ma GL, Chen X, et al.Contradictory links between lipid levels and bone health: Atherogenic index of plasma and bone microarchitecture[J]. J Orthop Surg Res, 2025, 20(1): 34. [4] 韩东旭, 梁倩, 王宇, 等. 2型糖尿病患者骨密度变化的相关危险因素分析[J]. 同济大学学报(医学版), 2023, 44(4): 502-510. [5] Anastasilakis AD, Paccou J, Palermo A, et al.The effects of anti-obesity medications on bone metabolism: A critical appraisal[J]. Diabetes Obes Metab, 2025, 27(9): 4674-4688. [6] Gruneisen E, Kremer R, Duque G.Fat as a friend or foe of the bone[J]. Curr Osteoporos Rep, 2024, 22(2): 245-256. [7] 林赟赟, 程鹏. 2型糖尿病患者脆性骨折风险增加的机制[J]. 南京医科大学学报(自然科学版), 2024, 44(10): 1441-1447. [8] 苏兰, 袁丽, 杨小玲. 不同糖代谢状态下绝经后骨质疏松症患者骨折情况的研究[J]. 实用医院临床杂志, 2024, 21(6): 70-73. [9] 刘思影, 王菲, 吴礼泽, 等. 基于孟德尔随机化分析多种代谢指标与乳腺癌发生的潜在因果关系[J]. 山西医科大学学报, 2026, 57(3): 250-257. [10] Chen Y, Lu T, Pettersson-Kymmer U, et al.Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases[J]. Nat Genet, 2023, 55(1): 44-53. [11] 李文晟, 胡添, 吕媛, 等. 类风湿性关节炎与眼部疾病的风险: 基于孟德尔随机化的研究[J]. 华南预防医学, 2025, 51(1): 30-35. [12] 高增杰, 李来来, 柴艺汇, 等. 基于孟德尔随机化方法分析炎症细胞因子与骨质疏松性椎体压缩骨折之间的因果关系[J]. 颈腰痛杂志, 2025, 46(5): 953-958. [13] 李娜, 陈欣欣, 陶爱萍, 等. 居家老人跌倒致髋部骨折的危险因素调查及预防再跌倒干预对策研究[J]. 实用预防医学, 2024, 31(7): 837-840. [14] Martiniakova M, Biro R, Penzes N, et al.Links among obesity, type 2 diabetes mellitus, and osteoporosis: Bone as a target[J]. Int J Mol Sci, 2024, 25(9): 4827. [15] Herrou J, Mabilleau G, Lecerf JM, et al.Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity[J]. Calcif Tissue Int, 2024, 114(2): 86-97. [16] Lin YH, Yip HT, Lin JJ, et al.Role of body fat and metabolic rate in site-specific fracture risk: A 20-year taiwanese cohort study[J]. Med Sci Monit, 2025, 31(31): 947660. [17] Beekman KM, Duque G, Corsi A, et al.Osteoporosis and bone marrow adipose tissue[J]. Curr Osteoporos Rep, 2023, 21(1): 45-55. [18] Zhao P, Sheng Z, Xu L, et al.Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence[J]. Elife, 2024, 12: 89281. [19] 郝丽美, 任文清, 秦林, 等. 转录组和多变量孟德尔随机化分析: 2型糖尿病与骨折的关系[J]. 湖南师范大学学报(医学版), 2024, 21(4): 97-105. [20] Sheu A, White CP, Center JR.Bone metabolism in diabetes: A clinician's guide to understanding the bone-glucose interplay[J]. Diabetologia, 2024, 67(8): 1493-1506. [21] Xiong X, Lui DTW, Ju C, et al.Associations of serum lipid traits with fracture and osteoporosis: A prospective cohort study from the UK biobank[J]. J Cachexia Sarcopenia Muscle, 2024, 15(6): 2669-2683. [22] Xiao H, Li W, Qin Y, et al.Crosstalk between lipid metabolism and bone homeostasis: Exploring intricate signaling relationships[J]. Research, 2024, 7(7): 447. [23] Grgurevic L, Novak R, Jambrošić L, et al.Systemic lipid metabolism dysregulation as a possible driving force of fracture non-unions?[J]. Bioengineering, 2024, 11(11): 1135. |